Previous 10 | Next 10 |
A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 118.4% to $0.1162 on volume of 394,556,402 shares U Power Limited (UCAR) rose 45.5% to $0.0959 on volume of 274,384,293 shares Palantir Technologies Inc. Class A (PLTR) rose 3.9% to $24.51 on v...
A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 164.5% to $0.1407 on volume of 378,097,862 shares U Power Limited (UCAR) rose 55.6% to $0.102517 on volume of 264,170,127 shares Palantir Technologies Inc. Class A (PLTR) rose 5.8% to $24.965 o...
2024-02-08 08:53:33 ET More on Pre-market losers & stocks. Peraso Inc. (PRSO) Q3 2023 Earnings Call Transcript Tenax surges after patent win for heart failure therapy Peraso to raise ~$4M through underwritten public offering of shares and warrants Financi...
2024-02-08 08:44:05 ET More on Tenax Therapeutics Tenax surges after patent win for heart failure therapy Tenax falls as rally driven by IND clearance cools Read the full article on Seeking Alpha For further details see: Tenax Therapeutics stock sinks aft...
CHAPEL HILL, N.C., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced today th...
Over 40 sites (U.S. and Canada) have agreed to participate in the LEVEL study LEVEL is a randomized, controlled Phase 3 trial of 152 patients, and will recruit patients primarily from leading research centers with large PH-HFpEF populations Tenax forecasts topline LEVEL ...
A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 8.5% to $23.725 on volume of 224,436,172 shares MicroCloud Hologram Inc. (HOLO) rose 602.0% to $10.6 on volume of 173,635,213 shares Snap Inc. Class A (SNAP) fell 34.8% to $11.37 on volum...
2024-02-07 10:00:01 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Lilly, Zoetis, Abbott least shor...
A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 30.8% to $21.87 on volume of 421,271,485 shares InVivo Therapeutics Holdings Corp. (NVIV) rose 136.9% to $0.526 on volume of 188,439,590 shares New York Community Bancorp Inc. (NYCB) fell...
2024-02-06 13:37:49 ET More on Tenax Therapeutics Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Seeking Alpha’s Quant Rating on Tenax Therapeutics Historical earnings data ...
News, Short Squeeze, Breakout and More Instantly...
Tenax Therapeutics Inc. Company Name:
TENX Stock Symbol:
NASDAQ Market:
Tenax Therapeutics Inc. Website:
Currently Enrolling Patients in Phase 3 LEVEL Study with 24 Investigative Sites Initiated Secured Global Development and Commercial Rights to Levosimendan for Treatment of PH-HFpEF Expanded Intellectual Property Estate for Levosimendan with Issuance of New U.S. Patent ...
Broadens IP protection for oral (TNX-103), IV, and subcutaneous use of levosimendan, and its active metabolites (OR1896 and OR1855), in PH-HFpEF Provides U.S. intellectual property (IP) protection until December 2040, and may qualify for additional U.S. patent term extension (PTE) beyond ...